Abstract
Gene therapy strategies designed to combat haemophilia B, caused by defects in clotting factor IX, have so far concentrated on ex vivo approaches. We have now evaluated adenoviral vector–mediated expression of human factor IX in vivo. Injection of the vector Av1H9B, which encodes human factor IX cDNA, into the tail veins of mice resulted in efficient liver transduction and plasma levels of human factor IX that would be therapeutic for haemophilia B patients. However, levels slowly declined to baseline by nine weeks and were not re–established by a second vector injection. These results address both the advantages and obstacles to the use of adenoviral vectors for treatment of haemophilia B.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Thompson, A.R. Stucture, function, and molecular defects of factor IX. Blood 67, 565–572 (1986).
Prevention and control of haemophilia: Memorandum from a joint WHO/WFA meeting. Bull. World Health Org. 69, 17–26 (1991).
Briet, E. Factor IX inhibitors in haemophilia B patients: their incidence and prospects for development with high purity factor IX products. Blood Coag. Fibrin. 2, (suppl 1) 47–50 (1991).
Hedner, U. & Davie, E.W. Introduction to hemostasis and the vitamin K dependent coagulation factors in The Metabolic Basis of Inherited Diseases Vol. 2, 6 edn (eds Scriver, C. R. et al.) 2116–2134 (McGraw-Hill, New York, N.Y. 1989).
Palmer, T.D., Thompson, A.R. & Miller, A.D. Production of Human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B. Blood 73, 438–445 (1989).
Scharfmann, R., Axelrod, J.H. & Verma, I.M. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. natn. Acad. Sci. U.S.A. 88, 4626–4630 (1991).
Yao, S.N., Wilson, J.M., Nabel, E.G., Kurachi, S., Hachiya, H.L. & Kurachi, K. Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B. Proc. natn. Acad. Sci. U.S.A. 88, 8101–8105 (1991).
Gerrard, A.J., Hudson, D.L., Brownlee, G.G. & Watt, F.M. Towards gene therapy for haemophilia B using primary human keratinocytes. Nature Genet. 3, 180–183 (1993).
Dai, Y., Roman, M., Naviaux, R.K. & Verma, I.M. Gene therapy in primary myoblasts: long-term expression of factor IX protein following transplantationin vivo. Proc. natn. Acad. Sci. U.S.A. 89, 10892–10895 (1992).
Berkner, K.L. Development of adenovirus vectors for the expression of heterologous genes. Bio Techniques 6, 616–629 (1988).
Rosenfeld, M.A. et al. Adenovirus-mediated transfer of a recombinant α1-antitrypsin gene to the lung epithelium in vivo.. Science 252, 431–434 (1991).
Rosenfeld, M.A. et al. in vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143–155 (1992).
Stratford-Perricaudet, L.D., Makeh, I., Perricaudet, M. & Briand, P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J. clin. Invest. 90, 626–630 (1992).
Mastrangeli, A. et al. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J. cin. Invest. 91, 225–234 (1993).
Davidson, B.L., Alien, F.D., Kozarsky, K.F., Wilson, J.M. & Roessler, B.J. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet. 3, 219–223 (1993).
Akli, S. et al. Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genet. 3, 224–228 (1993).
Bajocchi, G., Feldman, S.H., Crystal, R.G. & Mastrangeli, A. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genet. 3, 229–234 (1993).
Ragot, T. et al. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361, 647–650 (1993).
Stratford-Perricaudet, L.D., Levrero, M., Chasse, J., Perricaudet, M. & Briand, P. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum. gene Ther. 1, 241–256 (1990).
Jaffe, H.A. et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet. 1, 372–378 (1992).
Li, Q., Kay, M.A., Finegold, M., Stratford-Perricaudet, L.D. & Woo, S.L.C. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. gene Ther. 4, 403–409 (1993).
Herz, J. & Gerard, R.D. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. natn. Acad. Sci. U.S.A. 90, 2812–2816 (1993).
Human gene marker/therapy clinical protocols. Hum. gene Ther. 4, 391–398 (1993).
Evans, J.P., Watzke, H.H., Ware, J.L., Stafford, D.W. & High, K.A. Molecular cloning of a cDNA encoding canine factor IX. Blood 74, 207–212 (1989).
Thompson, A.R., Palmer, T.D., Lynch, C.M. & Miller, A.D. Gene transfer as an approach to cure patients with hemophilia A or B. in Biotechnology of Plasma Proteins. Curr. Stud. Hematol. Blood Transf. (eds Albertini, A. et al.) 58, 59–62 (Karger, Basel, 1991).
Thompson, A.R., Forrey, A.W., Gentry, P.A., Smith, K.J. & Harker, L.A. Human factor IX in animals: kinetics from isolated radiolabeled protein and platelet destruction following crude concentrate infusions. Br. J. Haematol. 45, 329–342 (1980).
Smith, K.J. & Thompson, A.R. Labeled factor IX kinetics in patients with hemophilia B. Blood 58, 625–629 (1981).
Jallat, S. et al. Characterization of recombinant human factor IX expressed in transgenic mice and in derived transimmortalized hepatic cell lines. EMBO J. 9, 3295–3301 (1990).
DiPersio, C.M., Jackson, D.A. & Zaret, K.S. The extracellular matrix coordinately modulates liver transcription factors and hepatocyte morphology. Molec. cell. Biol. 11, 4405–4414 (1991).
Horwitz, M.S. Adenoviruses in Fields Virology Vol. 2, 2 edn (eds Fields, B.N. & Knipe, D.M.) 1723–1742 (Raven Press, New York, 1990).
Strober, S. Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships. A. Rev. Immunol. 2, 219–237 (1984).
Mittal, S.K., McDermott, M.R., Johnson, D.C., Prevec, L. & Graham, F.L. Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res. 28, 67–90 (1993).
Shenk, T. & Williams, J. Genetic analysis of adenoviruses. Curr. Top. microbiol. Immunol. 111, 1–39 (1984).
Graham, F.L., Smiley, J., Russell, W.C. & Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. gen. Virol. 36, 59–72 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smith, T., Mehaffey, M., Kayda, D. et al. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 5, 397–402 (1993). https://doi.org/10.1038/ng1293-397
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng1293-397
This article is cited by
-
Controlled induction of DNA double-strand breaks in the mouse liver induces features of tissue ageing
Nature Communications (2015)
-
Transfection using hydroxyapatite nanoparticles in the inner ear via an intact round window membrane in chinchilla
Journal of Nanoparticle Research (2012)
-
Conditional Bicistronic Cre Reporter Line Expressing Both Firefly Luciferase and β-galactosidase
Molecular Imaging and Biology (2011)
-
Noninvasive Imaging of Lipid Nanoparticle–Mediated Systemic Delivery of Small-Interfering RNA to the Liver
Molecular Therapy (2010)
-
Suppression of peritoneal implantation of gastric cancer cells by adenovirus vector-mediated NK4 expression
Cancer Gene Therapy (2005)